January 23, 2018

Can Contact Force Sensing or Laser Balloon Decrease Atrial Fibrillation Ablation Failures?

While catheter ablation has been proven more effective at stopping atrial fibrillation than antiarrhythmic drugs, pulmonary veins may reconnect and atrial fibrillation may return, causing the catheter ablation to fail. At the recent Heart Rhythm Society meeting, Dr. Vivek Reddy, Director of Cardiac Arrhythmia Services at Mt. Sinai Hospital in New York City, presented clinical […]

Atrial Fibrillation Stroke Risk Decreases from Radiofrequency (RF) Catheter Ablation

A study presented at the recent American College of Cardiology Scientific Sessions by Dr. Matthew Reynolds of the Harvard Clinical Research Institute showed that having a radiofrequency (RF) catheter ablation for atrial fibrillation could reduce the risk of stroke by 40% compared to those who did not have an ablation. To learn more, see: Radiofrequency […]

Dr. Matthew Reynolds on Quality of Life From AF Ablation vs. Antiarrhythmic Drugs — Video

In this video, Dr. Matthew Reynolds, of the Harvard Clinical Research Institute, discussed his quality of life findings from use of catheter ablation and antiarrhythmic drugs for treatment of atrial fibrillation. He analyzed quality of life data that was collected as part of the THERMOCOOL catheter trial in which catheter ablation was found to be […]

Video of Mayo Clinic’s Dr. Doug Packer Explaining Landmark CABANA Atrial Fibrillation Trial

In this video, Dr. Douglas L. Packer of the Mayo Clinic provides details about the landmark CABANA Trial comparing Catheter Ablation to Antiarrhythmic Drugs for Atrial Fibrillation. Dr. Packer is the Lead Investigator for the CABANA Trial. Watch the video, and learn more, at: Dr. Douglas L. Packer on the CABANA Trial comparing Catheter Ablation to […]

Study Shows Women with Atrial Fibrillation (AF) Have Catheter Ablations Later Than Men, And Have Worse Results

New research from Dr. Andrea Natale and colleagues on gender disparities in atrial fibrillation points out that women with afib are less likely to have catheter ablation treatment than men. When they do have atrial fibrillation catheter ablations, they tend to be older and sicker, meaning that they are more likely to have persistent or […]

STOP AF Study Shows that Cryoablation Beats Antiarrhythmic Drugs for Paroxysmal Atrial Fibrillation Treatment

Important new research from the STOP AF Study of people with paroxysmal atrial fibrillation (AF) shows a type of catheter ablation called cryoablation worked better than drugs to control arrhythmias. One year after treatment, 69.9% of people treated with cryoablation had no episodes of afib compared to 7.3% of those who were treated with anti-arrhythmic […]

Is Catheter Ablation a Better Treatment Than Drugs for Atrial Fibrillation in Serious and Professional Athletes?

At the recent Boston Atrial Fibrillation Symposium, catheter ablation was presented as possibly a better atrial fibrillation (AF) treatment option for serious and professional athletes than antiarrhythmic drugs (AADs). According to Dr. Riccardo Cappato (Institute Policlinics San Donato, Milan, Italy), antiarrhythmic drug therapy has not been popular with this patient population.”Even when effective, AADs significantly […]

Prof. John Camm discusses dronedarone (Multaq) and vernakalant, new antiarrhythmic drugs for atrial fibrillation – Video

At Boston Atrial Fibrillation Symposium 2010, Prof. John Camm talked about the two newest antiarrhythmic drugs for atrial fibrillation treatment, dronedarone (Multaq®) and vernakalant. These antiarrhythmic (rhythm control) drugs help to put patients back into normal sinus rhythm, or to keep them in it. See the video: Interview with Professor John Camm at Boston Atrial […]

Atrial Fibrillation Research Study Seeks Those Who Have Taken Antiarrhythmic Drugs and are Near San Francisco, Cincinnati, or New Jersey

UPDATED 6-30-09: Study is now complete.  An afib research study is looking for afib patients who are near San Francisco, Cincinnati, or New Jersey/New York and who have taken certain anti-arrhythmic medications (Flecainide, Rythmol, Propafenone, and similar). They are offering an honorarium for your time. Find out if you qualify at: Atrial Fibrillation Research Study […]